MiR-770-5p inhibits cisplatin chemoresistance in human ovarian cancer by targeting ERCC2. - Zhao H; Yu X; Ding Y; Zhao J; Wang G; Wu X; Jiang J; Peng C; Guo GZ; Cui S (Oncotarget, 2016)